Role of IL-4, IL-13, and STAT6 in inflammation-induced hypercontractility of murine smooth muscle cells

被引:130
|
作者
Akiho, H [1 ]
Blennerhassett, P [1 ]
Deng, YK [1 ]
Collins, SM [1 ]
机构
[1] McMaster Univ, Hlth Sci Ctr, Intestinal Dis Res Program, Dept Med, Hamilton, ON L8N 3Z5, Canada
关键词
intestine; motility; cytokine;
D O I
10.1152/ajpgi.2002.282.2.G226
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
T helper 2 (Th2) cytokines interleukin (IL)-4 and IL-13, which activate signal transducer and activator of transcription 6 (STAT6) are expressed in the muscularis externa during nematode infection and are candidate mediators of the associated hypercontractility. To determine the locus of action of these cytokines, we examined the IL-4- and IL-13-induced hypercontractility of the isolated muscle cells from STAT6 +/+ and STAT6 -/- mice. We compared the results with cells isolated from Trichinella spiralis-infected STAT6 +/+ and STAT6 -/- mice. Carbamylcholine chloride (Carbachol) induced the contraction of jejunal muscle cells in a concentration-dependent manner maximal contraction (R-max 26.7+/-1.9%). Cells from T. spiralis-infected STAT6 -/- mice showed the hypertrophy (cell lengths 41.4+/-0.8 to 89.0+/-8.7 mum) and hypercontractility (R-max 37.5+/-1.3%) induced by infection. IL-4Ralpha mRNA was detected in dispersed smooth muscle cells. Incubation of longitudinal muscle-myenteric plexus (LMMP) with IL-4 and IL-13 enhanced Carbachol-induced muscle contraction (R-max 35.5+/-1.9 and 32.4+/-2.9%, respectively). Incubation of LMMP from STAT6 -/- mice with IL-4 did not enhance the contraction. The hypercontractility in T. spiralis-infected mice was attenuated in STAT6 -/- mice (P<0.02). These results indicate both IL-4 and IL-13 induce hypercontractility of muscle cells via the STAT6 pathway, and this is the basis for hypercontractility observed in T. spiralis-infected mice.
引用
收藏
页码:G226 / G232
页数:7
相关论文
共 50 条
  • [41] POTENT AND SELECTIVE ORAL STAT6 DEGRADERS INHIBIT IL-4 AND IL-13 FUNCTIONS IUN HUMAN CELLS AND BLOCK TH2 INFLAMMATION IN VIVO IN A MOUSE MODEL
    Wang, Amy
    Yang, Bin
    Ramanathan, Anand
    Hossain, Alamgir
    Dong, Huijun
    Follows, Bruce
    Browne, Chris
    Harsch, Andreas
    Sawant, Rupa
    Enerson, Bradley E.
    Slavin, Anthony
    Mainolfi, Nello
    GASTROENTEROLOGY, 2024, 166 (05) : S1352 - S1352
  • [42] IL-4 and STAT6 Drive RBC Alloimmunization
    Prakash, Anupam
    Medved, Jelena
    Salazar, Juan
    Li, Andria
    Luckey, Chance J.
    TRANSFUSION, 2018, 58 : 58A - 58A
  • [43] Stat6 regulation of in vivo IL-4 responses
    Finkelman, FD
    Morris, SC
    Orekhova, T
    Mori, M
    Donaldson, D
    Reiner, SL
    Reilly, NL
    Schopf, L
    Urban, JF
    JOURNAL OF IMMUNOLOGY, 2000, 164 (05): : 2303 - 2310
  • [44] IL-13/STAT6 signaling plays a critical role in the epithelialmesenchymal transition of colorectal cancer cells
    Cao, Hui
    Zhang, Jing
    Liu, Hong
    Wan, Ledong
    Zhang, Honghe
    Huang, Qiong
    Xu, Enping
    Lai, Maode
    ONCOTARGET, 2016, 7 (38) : 61183 - 61198
  • [45] Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma
    Agrawal, Swati
    Townley, Robert G.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (02) : 165 - 181
  • [46] Differential effects of interleukin (IL) 6 and IL-13 on pancreatic beta cell viability: the role of STAT6 signalling
    Russell, M. A.
    Cooper, A. C.
    Dhayal, S.
    Morgan, N. G.
    DIABETIC MEDICINE, 2013, 30 : 34 - 34
  • [47] IL-4 and IL-13 induced inhibition of osteoclast differentiation is associated with decreased expression of OSCAR and DAP12 in a STAT6 dependent pathway.
    Persson, E.
    Palmqvist, P.
    Granholm, S.
    Brechter, A.
    Lundberg, P.
    Lundgren, I.
    Lie, A.
    Conaway, H. H.
    Lerner, U. H.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S23 - S23
  • [48] IL-13 activates STAT6 and inhibits liver injury induced by ischemia/reperfusion
    Yoshidome, H
    Kato, A
    Miyazaki, M
    Edwards, MJ
    Lentsch, AB
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04): : 1059 - 1064
  • [49] Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma
    Oh, C. K.
    Geba, G. P.
    Molfino, N.
    EUROPEAN RESPIRATORY REVIEW, 2010, 19 (115): : 46 - 54
  • [50] IL-4 and IL-13 up-regulate intestinal trefoil factor expression: Requirement for STAT6 and de novo protein synthesis
    Blanchard, C
    Durual, S
    Estienne, M
    Bouzakri, K
    Heim, MH
    Blin, N
    Cuber, JC
    JOURNAL OF IMMUNOLOGY, 2004, 172 (06): : 3775 - 3783